ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IRON vs VKTX // FREE CASH FLOW YIELD

Disc Medicine Inc. (NASDAQ) VS. Viking Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IRON 7 — VKTX 1
▲ FREE CASH FLOW YIELD LEADER: IRON
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. VKTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IRON VKTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -27.50% -35.00% +7.50 IRON /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -4.93% -8.25% +3.32 IRON /fcf-yield <GO>
Operating Margin -22.90% — — TIE /operating-margins <GO>
Net Profit Margin -20.60% — — TIE /net-margins <GO>
Revenue Growth (YoY) 16.50% 15.40% +1.10 IRON /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 26.00 24.02 +1.98 IRON /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.4 48.3 +14.10 IRON /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.91 -0.01 VKTX /macro-sensitivity <GO>
Forward P/E Multiple 20.0x 35.0x -15.00 IRON /forward-pe <GO>
Enterprise Scale & Market Cap $3.59B $3.48B $109.9M IRON /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IRON REV VKTX REV IRON GROSS % VKTX GROSS % IRON FCF VKTX FCF
FY 2025 $660.9M $1.10B — — -$181.3M -$278.7M
FY 2024 $363.2M $422.6M — — -$94.4M -$87.8M
FY 2023 $255.2M $282.3M — — -$73.5M -$73.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
VKTX // BETA 0.91